top of page

India: CDSCO Grants Extension for Import Licenses of Class C and D Medical Devices

The Central Drugs Standard Control Organization (CDSCO) released a circular on 16 May announcing an extension for the importation of the Class C and D medical devices currently under application review with CDSCO. These classes of devices, which were to fall under the licensing regime starting from 1 October 2023 and the deadline was 1 April 2024, are now granted an additional 3 months for compliance.


The extension granted is due to concerns from associations and stakeholders requesting to avoid business continuity disruption because of the licensing implementation for class C and D medical devices.


Therefore, any importer or manufacturer who has been importing or manufacturing the involved medical devices, and has submitted the application on or before 30 September 2023, will be granted for the extension. The application will be considered valid, from the issuance date of this circular until the Central Licensing Authority reaches a decision, whichever comes earlier.

 


Contact us at info@arqon.com for more information.

6 views0 comments

Recent Posts

See All

Asia, Africa & Middle East - Nov/Dec 2019

Australia: Proposed changes to the Essential Principles for safety and performance Australia: Proposed changes to the requirements for systems and procedure packs Australia: Feedback sought on the reg

Asia, Africa & Middle East - Aug 2019

Australia: 2019 fees and charges released by the Therapeutic Goods Administration Australia: Conformity assessment standards for medical device QMSs Australia: TGA will no longer send out annual repor

Drugs - Aug 2019

China : NMPA No. 2019/34 Issuance of Provision n Drug Quality Inspection and and Testing EU/US : EMA/FDA Analysis Shows High Degree of Alignment in Marketing Application Decisions Between EU and US. S

Comments


bottom of page